Lymphoma is one of the most common and deadly cancers, ranking in the top 10…
Dr. Lauren WeinandJune 8, 2022
Treatment options for classical Hodgkin lymphoma (cHL) have expanded to the use of multiple chemotherapy…
Dr. Lauren WeinandJune 6, 2022
Photo by © ASCO/Nick Agro 2022. Written and edited by Lauren Weinand, M.D. Two groundbreaking…
Dr. Lauren WeinandJune 5, 2022
The conventional treatment modality for stage III or IV Hodgkin lymphoma has been doxorubicin, bleomycin,…
Dr. Lauren WeinandJune 3, 2022
Lymphoma is a common cancer that includes Hodgkin lymphoma (HL), among others. Excisional lymph node…
Dr. Lauren WeinandJune 2, 2022
There is insufficient data to address the incidence rate and risk factors for secondary lung…
Dr. Lauren WeinandJune 2, 2022
The goal of treatment for Hodgkin lymphoma (HL) in children is similar to that of…
Dr. Lauren WeinandJune 1, 2022
Hodgkin lymphoma (HL) is a rare but treatable disease that is curable in around 75%…
Dr. Lauren WeinandJune 1, 2022
Classical Hodgkin lymphoma (CHL) affects approximately 8,500 new patients each year, and the initial remission…
Dr. Lauren WeinandJune 1, 2022